Page 2 of 4 CV of Lawrence a Brown, M.D
Page 2 of 4 CV of Lawrence A Brown, M.D.
CURRICULUM VITAE
Lawrence Arthur Brown
3401 Greenway Unit 102
Baltimore, MD 21218-2601
410-522-8913
Work Experience
1989 – Present Staff Pathologist VAMHCS, Baltimore MD
1988 – 1989 Computer Consultant, Baltimore MD
1985 – 1988 Chief Biomedical Scientist,
Automated Diagnostic Systems, Inc, Arlington VA
1985 – 1985 Staff Pathologist, VAMC, Baltimore MD
1982 – 1985 Pathology Resident, UMMH, Baltimore MD
1981 – 1982 Internal Medicine Resident, MCV, Richmond VA
1980 – 1981 Pathology Resident, UMMH, Baltimore MD
1972 – 1978 Mathematician, Naval Ship Engineering Center, Washington DC
Academic Appointment
University of Maryland at Baltimore 1900 – Present
School of Medicine
Pathology Assistant Professor
Education
University of Maryland 1980 MD
School of Medicine
Baltimore MD 21201
The Johns Hopkins University 1976 BA
College of Arts & Sciences
Baltimore MD 21218
Certificates & Licenses
Anatomic & Clinical Pathology 1985 American Board of Pathology
Medical License 1980 Maryland
Honors
Clinical Pathology Resident Teaching Award 2001, 2006, 2009, 2010, 2012,
30 Years Federal Government Service 2011
Publications
1 Blood Donor deferrals by expert system
Sorace JM, Berman JJ, Brown LA, Moore GW
Proc Ann Symp Comput Appl Med Care 1990;14:610-614
2 Pathology image analysis system in a networked image capture system
Moore GW, Berman JJ, Brown LA, Richie SR, Kuzmak PM, Dayhoff RE
Demonstration NLIM July 28-30, 1993
3 Prostate-specific antigen screening for prostate cancer: no reduction in Gleason scores.
Berman JJ, Moore GW, Alonsozana EL, Brown LA.
Mod Pathol. 1994 May;7(4):487-9. PMID:7520587
4 Software for image segmentation and analysis in pathology (ISAP)(Abstract): public domain image software and source code developed at the Baltimore VA Medical Center
Moore GW, Berman JJ, Brown LA
Am J Clin Pathol 1994; 102:538-539
5 Goedelization of Pathology Database: Re-identification by Inference (Abstract)
Moore GW, Brown LA, Miller RE
Am J Clin Pathol 1994; 102:538-539
6 PSA screening and prostate cancer incidence.
Berman JJ, Moore GW, Alonsozana EL, Brown LA.
JAMA. 1996 Apr 17;275(15):1155-6. PMID:8609674
7 Health effects of depleted uranium on exposed Gulf War veterans.
McDiarmid MA, Keogh JP, Hooper FJ, McPhaul K, Squibb K, Kane R, DiPino R, Kabat M,
Kaup B, Anderson L, Hoover D, Brown L, Hamilton M, Jacobson-Kram D, Burrows B,
Walsh M.
Environ Res. 2000 Feb;82(2):168-80. PMID:10662531
8 Set Theory Definition and Algorithm for Medical De-Identification (Abstract)
Moore GW, Brown LA, Miller RE
Arch Pathol Lab Med 2001 Jun;125:8xx
9 Surveillance of depleted uranium exposed Gulf War veterans: health effects observed in an enlarged "friendly fire" cohort.
McDiarmid MA, Squibb K, Engelhardt S, Oliver M, Gucer P, Wilson PD, Kane R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Jacobson-Kram D; Depleted Uranium Follow-Up Program.
J Occup Environ Med. 2001 Dec;43(12):991-1000. PMID:11765683
10 Health effects of depleted uranium on exposed Gulf War veterans: a 10-year follow-up.
McDiarmid MA, Engelhardt S, Oliver M, Gucer P, Wilson PD, Kane R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Handwerger B, Albertini RJ, Jacobson-Kram D, Thorne CD, Squibb KS.
J Toxicol Environ Health A. 2004 Feb 27;67(4):277-96. PMID:14713562
11 Biological monitoring and surveillance results of Gulf War I veterans exposed to depleted uranium.
McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, Kane R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Albertini RJ, Gudi R, Jacobson-Kram D, Thorne CD,
Squibb KS.
Int Arch Occup Environ Health. 2006 Jan;79(1):11-21. Epub 2005 Aug 2. PMID:16075297
12 Health surveillance of Gulf War I veterans exposed to depleted uranium: updating the cohort.
McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, Kane R, Cernich A, Kaup B, Anderson L, Hoover D, Brown L, Albertini R, Gudi R, Jacobson-Kram D, Squibb KS.
Health Phys. 2007 Jul;93(1):60-73. PMID:17563493
13 Surveillance results of depleted uranium-exposed Gulf War I veterans: sixteen years of follow-up.
McDiarmid MA, Engelhardt SM, Dorsey CD, Oliver M, Gucer P, Wilson PD, Kane R, Cernich A, Kaup B, Anderson L, Hoover D, Brown L, Albertini R, Gudi R, Squibb KS.
J Toxicol Environ Health A. 2009;72(1):14-29. PMID:18979351
14 Longitudinal health surveillance in a cohort of Gulf War veterans 18 years after first exposure to depleted uranium.
McDiarmid MA, Engelhardt SM, Dorsey CD, Oliver M, Gucer P, Gaitens JM, Kane R, Cernich A, Kaup B, Hoover D, Gaspari AA, Shvartsbeyn M, Brown L, Squibb KS.
J Toxicol Environ Health A. 2011;74(10):678-91. PMID:21432717
15 The Gulf War depleted uranium cohort at 20 years: bioassay results and novel approaches to fragment surveillance. McDiarmid MA, Gaitens JM, Hines S, Breyer R, Wong-You-Cheong JJ, Engelhardt SM, Oliver M, Gucer P, Kane R, Cernich A, Kaup B, Hoover D, Gaspari AA, Liu J, Harberts E, Brown L, Centeno JA, Gray PJ, Xu H, Squibb KS.
Health Phys. 2013 Apr;104(4):347-61. PMID: 23439138
16 The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.
Shuldiner AR, Relling MV, Peterson JF, Hicks JK, Freimuth RR, Sadee W, Pereira NL, Roden DM, Johnson JA, Klein TE; Pharmacogenomics Research Network Translational Pharmacogenetics Program Group, Shuldiner AR, Vesely M, Robinson SW, Ambulos N Jr, Stass SA, Kelemen MD, Brown LA, Pollin TI, Beitelshees AL, Zhao RY, Pakyz RE, Palmer K, Alestock T, O'Neill C, Maloney K, Branham A, Sewell D, Relling MV, Crews K, Hoffman J, Cross S, Haidar C, Baker D, Hicks JK, Bell G, Greeson F, Gaur A, Reiss U, Huettel A, Cheng C, Gajjar A, Pappo A, Howard S, Hudson M, Pui CH, Jeha S, Evans WE, Broeckel U, Altman RB, Gong L, Whirl-Carrillo M, Klein TE, Sadee W, Manickam K, Sweet KM, Embi PJ, Roden D, Peterson J, Denny J, Schildcrout J, Bowton E, Pulley J, Beller M, Mitchell J, Danciu I, Price L, Pereira NL, Weinshilboum R, Wang L, Johnson JA, Nelson D, Clare-Salzler M, Elsey A, Burkley B, Langaee T, Liu F, Nessl D, Dong HJ, Lesko L, Freimuth RR, Chute CG.
Clin Pharmacol Ther. 2013 Aug;94(2):207-10. doi: 10.1038/clpt.2013.59. Epub 2013 Mar 19. No abstract available. PMID: 23588301
17 Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.
Shuldiner AR, Palmer K, Pakyz RE, Alestock TD, Maloney KA, O'Neill C, Bhatty S, Schub J, Overby CL, Horenstein RB, Pollin TI, Kelemen MD, Beitelshees AL, Robinson SW, Blitzer MG, McArdle PF, Brown L, Jeng LJ, Zhao RY, Ambulos N, Vesely MR.Am J Med Genet C
Semin Med Genet. 2014 Mar;166C(1):76-84. doi: 10.1002/ajmg.c.31396. Epub 2014 Mar 10.PMID: 24616408
18 Biologic monitoring and surveillance results for the department of veterans affairs' depleted uranium cohort: Lessons learned from sustained exposure over two decades. McDiarmid MA Gaitens JM Hines S Condon M Roth T Oliver M Gucer P Brown L Centeno JA Streeten E Squibb KS, Am J Ind Med. 2015 Jun;58(6):583-94
19 The U.S. Department of Veterans' Affairs depleted uranium exposed cohort at 25 Years: Longitudinal surveillance results. McDiarmid MA, Gaitens JM, Hines S, Condon M, Roth T, Oliver M, Gucer P, Brown L, Centeno JA, Dux M, Squibb KS.Environ Res. 2017 Jan;152:175-184. doi: 10.1016/j.envres.2016.10.016. PMID: 27792941